Related Experiment Videos
Editors' roundtable: Current formulas for P & T Committee success (Part 1)
Insights
Hospital Pharmacy and Therapeutics (P&T) Committees are vital for healthcare, with their influence growing. Experts discuss challenges like new technologies and cost containment, offering strategies for success.
Area of Science:
- Health Services Research
- Pharmacy Administration
Background:
- Hospital Pharmacy and Therapeutics (P&T) Committees play a crucial role in drug formulary management and healthcare decision-making.
- The evolving healthcare landscape, particularly prospective reimbursement, is increasing the visibility and influence of P&T Committees.
Purpose of the Study:
- To gather insights from leading editors on critical issues facing hospital P&T Committees.
- To explore current challenges and successful strategies for P&T Committees in managing drug formularies and healthcare costs.
Main Methods:
- A roundtable discussion format involving four editors of Hospital Formulary.
- Qualitative analysis of expert opinions on P&T Committee functions and challenges.
Main Results:
- P&T Committees are perceived as highly visible and functional, with anticipated increased influence.
- Key challenges include managing new therapeutic entities, off-label drug use, and continuous medical staff education.
- Cost containment while maintaining patient care quality is a paramount and growing concern.
Conclusions:
- P&T Committees are essential components of the healthcare system, adapting to new challenges.
- Proactive strategies are necessary for P&T Committees to effectively navigate technological advancements, regulatory changes, and financial pressures.
- The future role of P&T Committees is expected to expand, requiring ongoing adaptation and strategic planning.
Abstract:
In this roundtable discussion, the four editors of Hospital Formulary--Arthur G. Lipman, Pharm D, Harold C. Neu, MD, Bramah N. Singh, MD, PhD, and Michael Weintraub, MD--share their views on key issues that affect hospital P & T Committees. They agree that the P & T Committee is both highly visible and functions well, and they predict that its influence in the health care system wil heighten as prospective reimbursement continues. Challenges P & T Committees are confronted with today, such as therapeutic entities from new technologies, use of approved drugs for unapproved indications, and the need for educating and re-educating the medical staff are discussed. Cost containment continues to become a more and more important consideration with maintained patient care quality. Successful strategies for coping with and benefiting from these challenges are presented.